Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Deficit)

v3.22.2
Condensed Consolidated Statements of Equity (Deficit) - USD ($)
$ in Thousands
Total
Cumulative effect adjustment for ASC 842 lease accounting adoption
Private Placement
Underwritten Public Offering
Parent
Parent
Cumulative effect adjustment for ASC 842 lease accounting adoption
Parent
Private Placement
Parent
Underwritten Public Offering
Preferred Stock Issued
Common Stock Issued
Common Stock Issued
Private Placement
Common Stock Issued
Underwritten Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Underwritten Public Offering
Accumulated Deficit
Accumulated Deficit
Cumulative effect adjustment for ASC 842 lease accounting adoption
Noncontrolling interest
Beginning balance (in shares) at Aug. 31, 2020                 0 16,902,146                
Beginning balance at Aug. 31, 2020 $ (30)       $ (30)       $ 0 $ 1     $ 119,431     $ (119,462)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common stock issued, net of offering costs (in shares)                     2,320,000 4,000,000            
Common stock issued, net of offering costs     $ 11,063 $ 10,701     $ 11,063 $ 10,701     $ 1     $ 11,062 $ 10,701      
Common stock issued for convertible securities (in shares)                 (12,500) 12,500                
Stock-based compensation expense 1,250       1,250               1,250          
Excess fair value of SPAC Founder shares transferred to underwriters 47,472                                 47,472
Preferred stock issued for preferred option exercised (in shares)                 12,500                  
Net Loss (20,647)       (20,647)                     (20,647)    
Ending balance (in shares) at May. 31, 2021                 0 23,234,646                
Ending balance at May. 31, 2021 49,809       2,337       $ 0 $ 2     142,444     (140,109)   47,472
Beginning balance (in shares) at Aug. 31, 2020                 0 16,902,146                
Beginning balance at Aug. 31, 2020 (30)       (30)       $ 0 $ 1     119,431     (119,462)   0
Ending balance (in shares) at Aug. 31, 2021                 0 25,863,099                
Ending balance at Aug. 31, 2021 $ 40,923 $ 608     (6,549) $ 608     $ 0 $ 3     142,786     (149,338) $ 608 47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]                                  
Beginning balance (in shares) at Feb. 28, 2021                 0 20,914,646                
Beginning balance at Feb. 28, 2021 $ (1,585)       (1,585)       $ 0 $ 1     130,995     (132,581)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common stock issued, net of offering costs (in shares)                     2,320,000              
Common stock issued, net of offering costs     11,063       11,063       $ 1     11,062        
Stock-based compensation expense 387       387               387          
Excess fair value of SPAC Founder shares transferred to underwriters 47,472                                 47,472
Net Loss (7,528)       (7,528)                     (7,528)    
Ending balance (in shares) at May. 31, 2021                 0 23,234,646                
Ending balance at May. 31, 2021 49,809       2,337       $ 0 $ 2     142,444     (140,109)   47,472
Beginning balance (in shares) at Aug. 31, 2021                 0 25,863,099                
Beginning balance at Aug. 31, 2021 40,923 608     (6,549) 608     $ 0 $ 3     142,786     (149,338) 608 47,472
Ending balance (in shares) at Feb. 28, 2022                 0 33,661,552                
Ending balance at Feb. 28, 2022 $ (10,727)       (20,221)       $ 0 $ 3     146,716     (166,940)   9,494
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]                                  
Beginning balance (in shares) at Aug. 31, 2021                 0 25,863,099                
Beginning balance at Aug. 31, 2021 $ 40,923 $ 608     (6,549) $ 608     $ 0 $ 3     142,786     (149,338) $ 608 47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common stock issued, net of offering costs (in shares)                     2,850,000              
Common stock issued, net of offering costs     $ 4,183       $ 4,183             $ 4,183        
Common stock issued for convertible securities (in shares)                   9,621,774                
Common stock issued for convertible securities 5,410       5,410         $ 1     5,409          
Prefunded warrants from private placement, net of offering costs 6,861       6,861               6,861          
Stock-based compensation expense 1,069       1,069               1,069          
Excess fair value of SPAC Founder shares transferred to underwriters 0                                  
Remeasurement of IHC temporary equity (13,431)       (13,431)               (13,431)          
Withdrawal of SPAC registrations under Form S-1 (37,978)                                 (37,978)
Net Loss (31,037)       (31,037)                     (31,037)    
Ending balance (in shares) at May. 31, 2022                 0 38,334,873                
Ending balance at May. 31, 2022 (23,392)       (32,886)       $ 0 $ 4     146,877     (179,767)   9,494
Beginning balance (in shares) at Feb. 28, 2022                 0 33,661,552                
Beginning balance at Feb. 28, 2022 (10,727)       (20,221)       $ 0 $ 3     146,716     (166,940)   9,494
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common stock issued for convertible securities (in shares)                   4,673,321                
Common stock issued for convertible securities 1       1         $ 1                
Stock-based compensation expense 321       321               321          
Remeasurement of IHC temporary equity (160)       (160)               (160)          
Net Loss (12,827)       (12,827)                     (12,827)    
Ending balance (in shares) at May. 31, 2022                 0 38,334,873                
Ending balance at May. 31, 2022 $ (23,392)       $ (32,886)       $ 0 $ 4     $ 146,877     $ (179,767)   $ 9,494